Arena Pharma Declines As Analyst Salshes Rating
Thu, 03/29/2012 - 08:16 | 
Shares of Arena Pharmaceuticals declined Wednesday after a Piper Jaffray forecaster demoted the stock, mentioning that the share cost has developed as Wall Street turns more promising that Arena's obesity medication lorcaserin will get sanctioned.
Dr Reddy’s Laboratories, Sun Pharma and Lupin Ltd have received a final nod for their Quetiapine Fumaratac tabs of 25 mg, 50 mg, 100 mg, 200 mg, 300 mg and 400 mg intensities from USFDA.
Maker of generic pharmaceuticals and active pharma components Aurobindo Pharma Ltd. declared that the company had received final authorizations from the USFDA to sell Quetiapine Fumarate tabs 25mg, 50mg, 100mg, 150mg, 200mg, 300mg and 400mg.
Tags: Watson Pharma Seeks FDA Nod For Cholesterol Drug Niaspan
Generic drug maker Watson Pharmaceuticals Inc. stated that it is seeking favorable reception from the Food and Drug Administration to sell a generic edition of Abbott Laboratories' cholesterol medication Niaspan.
Stock market analyst Siddharth Bhamre, Angel Broking, has maintained buy rating on Aurobindo Pharma stock with a target of Rs 132.
Mankind Pharma, a large pharmaceutical firm, is making entry in the eye care and skin treatment group and proposes to introduce two novel products in the market shortly.
Dr Reddy’s Registers 88% Jump In Quarterly Profit
Dr Reddy’s Laboratories , the country's No. 2 drug manufacturer by sales, registered a forecast-hitting 88% increase in quarterly net profit as sales in its main U.S. market increased over two-folds.
Nirmal Bang has suggested ‘hold’ rating on Glenmark Pharma to attain a price target of Rs 364.
British drug manufacturer AstraZeneca declared that it has decided to slash costs by shutting its Quebec research and development plant, annihilating 132 jobs.
Poland's retail pharma market posted a drop of 24% year on year during the last month to PLN 1.4 billion in gross retail prices.
